it is concluded that : ( a ) continuous systemic corticosteroid therapy in mean doses of more than 5 mg/day of prednisone equivalent is now rarely indicated in patients with steroid-dependent asthma , and ( b ) inhaled corticosteroid therapy with bdp could be extended to cases of non steroid-dependent asthma inadequately controlled by bronchodilators .
C0004906
bdp
C0004096
asthma